window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-W287TTH7MD');

Partner in the Spotlight

Two new COLOSSUS publications from Prof. Livio Trusolino’s group

2023-07-24T12:39:01+00:00March 24th, 2023|

Congratulations to our partners at the Universita degli Studi di Torino and their collaborators for two recent COLOSSUS-acknowledged publications! The first was a review titled "Towards precision oncology with patient-derived xenografts" which was published in Nature Reviews Clinical Oncology in November 2022. The authors/researchers involved were Eugenia R. Zanella, Elena Grassi and Livio Trusolino. DOI: [...]

Interview with Professor Diether Lambrechts, VIB

2023-03-06T10:59:50+00:00February 28th, 2023|

Danielle Nicholson at Pintail Limited posed a set of questions to Professor Diether Lambrechts of the VIB about his research and career. Can you give a tip or two to those aiming to become successful, leading academic researchers? Professor Diether Lambrechts I believe that there are several ways you can become an academic research [...]

Understanding the Health Economics of Colorectal Cancer: A COLOSSAL undertaking

2022-09-08T08:40:37+00:00September 8th, 2022|

The Royal College of Surgeons in Ireland's Dr Jonathan Briody contributed an editor-invited piece on colorectal cancer for the 'oncology focus' issue of Hospital Professional News this September (2022): "Understanding the Health Economics of Colorectal Cancer: A COLOSSAL undertaking". Dr Briody is a health economist conducting an economic evaluation of the cost-effectiveness of precision medicine for [...]

Spotlight on The Institute of Cancer Research (ICR), UK

2022-06-30T07:54:59+00:00June 30th, 2022|

In the Systems and Precision Cancer Medicine team at The Institute of Cancer Research, the ICR, the research focuses on translational cancer research and patient benefit and leverages national and international clinical trials and tissue resources. Their interdisciplinary work effectively integrates experimental, computational and clinical biology. Cancers are highly heterogeneous at molecular and phenotypic levels, [...]

Translational Models of Colorectal Cancer: Università degli Studi di Torino

2022-06-28T08:36:41+00:00June 28th, 2022|

Recent technological advances have provided powerful insights into the molecular determinants of human tumours. In many cases, tumour regression has been the result of blocking a single mutant protein responsible for both the initiation and maintenance of the cancer, called an oncogenic driver mutation. Often oncogenic driver mutations are found in the very genes responsible [...]

Video of RCSI’s seminar on health economics is now available

2022-05-31T11:12:20+00:00May 31st, 2022|

If you missed the recent RCSI-hosted seminar on health economics, titled "Policies to Reduce Drug Expenditure Without Harming Patients," the video is now available. https://youtu.be/iSQTBp_GmDg Dr Jonathan Briody Dr Briody would like to thank Dr Goldstein for presenting and the attendees for their engagement. He believes this seminar on health economics in [...]

COLOSSUS research presented by Aoife Nolan, UCD at IACR meeting in Cork

2022-04-01T16:48:33+00:00March 14th, 2022|

University College Dublin's PhD candidate Aoife Nolan facilitated an oral poster presentation entitled "Investigation of KRAS mutant Effect on Cell Signalling and Protein Expression Profiles in Microsatellite Stable Colorectal Cancer" featuring her COLOSSUS research at the 2022 conference of the Irish Association for Cancer Research. This meeting is taking place face-to-face from the 30th of [...]

New premises and collaboration: RCSI and Cancer Trials Ireland

2022-01-11T15:03:50+00:00January 10th, 2022|

Dr Murphy Dr Verena Murphy, Head of Research and Business Development at Cancer Trials Ireland reports that their operations have moved offices from Glasnevin to Ardilaun House, a Royal College of Surgeons in Ireland (RCSI) building at St Stephen’s Green, Dublin as part of their new partnership with the RCSI. The RCSI and [...]

Congratulations Wolf H Fridman!

2022-01-07T15:42:28+00:00January 7th, 2022|

COLOSSUS PI Wolf Hervé Fridman (left), Professor Emeritus of Immunology, University of Paris Medical School and the Institut National de la Sante et de la Recherche Medicale in Paris (INSERM) has been awarded the ESMO Immuno-Oncology Award 2021  for his outstanding achievements in immuno-oncology. Prof. Fridman whose research has made significant contributions to unveiling the [...]

Go to Top